Endocrine Society Opposes Graham-Cassidy

In a letter to Senate Majority Leader Mitch McConnell (R-KY) and Senate Minority Leader Chuck Schumer (D-NY), the Endocrine Society is calling for a bipartisan effort to focus on market stabilization as opposed to the recent proposal to end the Affordable Care Act brought by Republican senators Lindsay Graham (R-SC) and Bill Cassidy (R-LA).

Authored by Endocrine Society CEO Barbara Byrd Keenan, the letter states that this new proposal would negatively impact patients’ access to adequate and affordable health coverage, preventive services, and patient-centered care.

Here is the rest of the letter in full:

“Our members care for people with complex, chronic diseases, such as diabetes, obesity, osteoporosis, infertility, rare cancers and thyroid conditions. These diseases affect growing numbers of people, placing stress on the health care system. Our more than 18,000 members care for patients and are dedicated to advancing hormone research and excellence in the clinical practice of endocrinology. We promote policies to help ensure that all individuals with endocrine diseases have access to high quality, specialized care and adequate, affordable health insurance.

We would like to work with both sides of the aisle to ensure that the needs of endocrine patients are fully considered as policies affecting access to health insurance and the healthcare system are considered.

Affordable, adequate care is vital to the patients we represent. This legislation fails to provide Americans with what they need to maintain their health. It would limit funding for the Medicaid program, roll back important essential health benefit protections, and potentially allow annual and lifetime caps on coverage, endangering access to critical care for millions of Americans. In addition, it also fails to achieve the other principles our Society has identified for health reform legislation: inclusion of preventive health benefits and maintenance of the Prevention and Public Health Fund; creation of new care models focused on providing coordinated care for people who are treated by multiple health care providers; and protection of women’s health, including ensuring that all women have continued access to necessary health care services, contraception, and preventive screenings.

Instead of this legislation, we urge you to continue the bipartisan effort led by Chairman Lamar Alexander and Ranking Member Patty Murray in the Senate Health, Education, Labor and Pensions (HELP) Committee and by Chairman Orrin Hatch and Ranking Member Ron Wyden in the Senate Finance Committee focused on market stabilization and other critical issues.

We urge you to continue bipartisan efforts rather than advancing a proposal that would weaken access to the care Americans need and deserve, and we would like to work with both sides of the aisle to ensure that the needs of endocrine patients are fully considered as policies affecting access to health insurance and the healthcare system are considered.”

You may also like

  • Destination Albuquerque: Previewing the 1st International Conference on Steroid Hormones and Receptors

    Building on a legacy that has lasted for a quarter of a century and now sponsored by the Endocrine Society, the 1st International Conference on Steroid Hormones and Receptors will be held next month at University of New Mexico Comprehensive Cancer Center in Albuquerque. Endocrine News talks to conference chairs Eric R. Prossnitz, PhD, and…

  • Meet New Endocrine Society President, John Newell-Price, MD, PhD

    The Endocrine Society is pleased to welcome its president for 2024 – 2025, John Newell-Price, MD, PhD, FRCP, who took office during ENDO 2024 in Boston. Newell-Price is Professor of Endocrinology at the University of Sheffield, United Kingdom. He is also head of the Endocrinology Service at Sheffield Teaching Hospitals NHS Foundation Trust and of…

Find more in